Arcutis Biotherapeutics
Price & Volume
Stats
See more52W Range | $11.13-$31.10 |
Market Cap | $3.7B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $317.9M |
Revenue Growth (YoY) | 121.7% |
Gross Profit (12 Mos) | $286M |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 14 hours ago
Netflix target cut, Five Below target raised: Wall Street's top analyst calls
Yahoo Finance • 12 days ago
FDA Accepts Arcutis' SNDA To Expand Zoryve Use To Children Aged 2-5
Yahoo Finance • 12 days ago
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5
Yahoo Finance • 21 days ago
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Todd Franklin Watanabe M.A. |
Address | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 342 |
